Preimplantation genetic diagnosis market

Preimplantation Genetic Diagnosis Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Š Coherent market Insights. All Rights Reserved

Preimplantation genetic diagnosis (PGD) is the genetic profiling of the pre implantable embryos and oocytes before their implantation. The preimplantation genetic diagnosis is similar to that of the parental diagnosis in case of screening for a particular genetic disease. The PGD is advantageous in a way that it helps to avoid the selective pregnancy termination by development and growth of healthy fetus. PGD serves as an addendum to assisted reproductive technology. The preimplantation genetic diagnosis is required in vitro fertilization, in order to obtain oocytes from the embryos for the genetic evaluation of diseased or disease free condition. In simpler terms, the preimplantation genetic diagnosis is technique that is used to identify embryos at risk. The process involves DNA analysis, to figure out mutations or previous records of genetic or chromosomal disorders in the family, with the help of a procedure known as preimplantation genetic profiling.

Growing rates in birth defects creating opportunities for expansion of the global preimplantation genetic diagnosis market A vast data is available reporting birth defects as well as infant mortality. According to World Health Organization (WHO) and March of Dimes (MOD) joint report in 2013, the prevalence of birth defects in India is 61 to 70 per 1000 live births. The report also mentions that, 70% of these birth defects are preventable giving opportunities for the growth preimplantation genetic diagnosis market. Scientific report in the Nature journal states that, 7.9 million infants accounting up to 6% of the worldwide births are born with serious birth defects, out of which more than 50% defects are unknown. These defects may be due to chromosomal abnormalities that could be investigated using preimplantation genetic diagnosis preventing defective births and propelling the global market.

Š Coherent market Insights. All Rights Reserved

The global preimplantation genetic diagnosis market is segmented on the basis of test types and geographical regions.

On the basis of test types: Chromosomal Abnormalities Gender Selection X- Linked Diseases Aneuploidy Single Gene Disorders Others The chromosomal abnormality segment has witnessed a huge adoption in the global PGD market. This owes to rise in hereditary, genetic, and chromosomal diseases. However, stringent regulations abiding to restriction of gender selection are obstructing the market growth.

Regional growth engines of the global preimplantation genetic diagnosis market Based on the geographical segmentation, the global preimplantation genetic diagnosis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe is dominating the market attributing to increase in number of late pregnancies, which are mostly expected to be IVFs. Request for sample copy of this report : https://www.coherentmarketinsights.com/insight/request-sample/698

Š Coherent market Insights. All Rights Reserved

Increasing awareness among the population regarding prevention of genetic diseases and reproduction health propelling the global preimplantation genetic diagnosis market The primary reason to boost the market growth is increasing awareness among people to undergo diagnostic tests in order to prevent birth defects. According to the National Institutes of Health (NIH), which aims for biomedical and public health research, about 50% children are affected by rare diseases. These diseases may include chromosomal defects as well as hereditary disorders. Several other factors contributing to the global preimplantation genetic diagnosis market growth include, high demand of people seeking for in vitro fertilization treatments and advancements in the PGF availing diagnosis of diseases such as cancer and minor disabilities such as deafness. However, ethical issues related to sex determination and stringent regulations regarding sex determination and sex differentiation could hinder the growth of the market.

The key players operating the lbal preimplantation genetic diagnosis market include Abbott Laboratories, Illumina, Inc., Natera Inc., PerkinElmer, Inc., F. Hoffman-La-Roche Ltd, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Inc., Reproductive Genetics Institute and Genea Ltd. These players are consistently involved in enhancing efficiency of the diagnosis process providing better healthcare solutions to the global population.

Get discount on this report : https://www.coherentmarketinsights.com/insight/request-discount/698

Š Coherent market Insights. All Rights Reserved

ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide.

We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods.

We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.

SERVICES INDUSTRY ANALYSIS

CUSTOMIZED RESEARCH

MARKET INTELLIGENCE SERVICES

CONSULT STUDIES

Š Coherent market Insights. All Rights Reserved

SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES

ABOUT COHERENT MARKET INSIGHTS Industries we cater SECTOR COVERAGE Healthcare

BIOTECHNOLOGY

CLINICAL DIAGNOSTIC

HEALTHCARE IT

MEDICAL DEVICES

MEDICAL IMAGING

PHARMACEUTICAL

Chemicals & Materials

Bulk Chemicals

Advanced Materials

Speciality and Fine Chemicals Green Chemicals

Food Ingredients

© Coherent market Insights. All Rights Reserved

Cosmetic Ingredients

Polymers & Resins

ABOUT COHERENT MARKET INSIGHTS KEY STATS

RESEARCH SOLUTIONS

FEASIBILITY STUDIES

GLOBAL REPORTS

100+

Insights Published Per Year

150+

Consulting Projects Till Date

125+

Clients Worldwide Per Year

110+

COUNTRY ANALYSIS

CONSULT PROJECTS

SURVEY RESEAR CH

EXCEL FORECAST DATABASE

CUSTOMIZED SOLUTIONS

COMPETITIVE ASSESSMENT

TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

THANK YOU

To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

Š Coherent market Insights. All Rights Reserved